WB214

N/A

Report date: 2023/12/14 17:54:42
NME

Base Information

Drug NameWB214
Drug Alias NameWB-214
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)Small molecules > Molecular Glue
Mechanisms of Actionp53-binding protein Mdm-2 inhibitorsProteolysis
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-Madison
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Wisconsin-Madison
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A